You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

rho kinase

Showing 1 - 25 of 2,065
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy Trial in Philadelphia (Netarsudil 0.02% Ophthalmic Solution

Not yet recruiting
  • Rhegmatogenous Retinal Detachment
  • Proliferative Vitreoretinopathy
  • Netarsudil 0.02% Ophthalmic Solution [RHOPRESSA]
  • Glycerin 0.2%/Hypromellose 0.2%/Peg 1%/Soln,Oph,Ud
  • Philadelphia, Pennsylvania
    Wills Eye Physicians - Mid Atlantic Retina
Dec 13, 2022

Amyotrophic Lateral Sclerosis Trial in France, Germany, Switzerland (Fasudil, Placebo)

Active, not recruiting
  • Amyotrophic Lateral Sclerosis
  • Marseille, France
  • +14 more
Jun 2, 2022

Progressive Supranuclear Palsy, Corticobasal Syndrome Trial in San Francisco (Fasudil)

Active, not recruiting
  • Progressive Supranuclear Palsy
  • Corticobasal Syndrome
  • San Francisco, California
    University of California Weill Institute for Neurosciences
May 31, 2022

Amyotrophic Lateral Sclerosis Trial in Australia, United States (Fasudil (WP-0512))

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Fasudil (WP-0512)
  • Phoenix, Arizona
  • +11 more
Oct 28, 2022

Chronic GVHD Trial in United States (drug, procedure, other)

Not yet recruiting
  • Chronic Graft Versus Host Disease
  • Tampa, Florida
  • +4 more
Aug 10, 2023

Glaucoma, Open-Angle Trial in San Antonio (Netarsudil Ophthalmic)

Unknown status
  • Glaucoma, Open-Angle
  • Netarsudil Ophthalmic
  • San Antonio, Texas
    University of the Incarnate Word
Apr 12, 2020

Corneal Edema Trial in San Salvador (HCEC-1)

Active, not recruiting
  • Corneal Edema
  • San Salvador, El Salvador
    Clinica Quesada
Mar 24, 2022

Fuchs Trial in United States (Topical Ripasudil, Topical Placebo)

Recruiting
  • Fuchs
  • Topical Ripasudil
  • Topical Placebo
  • Palo Alto, California
  • +3 more
Jan 18, 2023

GVHD Trial in Hackensack (Telmisartan)

Active, not recruiting
  • GVHD
  • Hackensack, New Jersey
    Hackensack University Medical Center
Sep 2, 2022

Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy Trial (Netarsudil Ophthalmic)

Not yet recruiting
  • Rhegmatogenous Retinal Detachment
  • Proliferative Vitreoretinopathy
  • Netarsudil Ophthalmic
  • (no location specified)
Sep 9, 2023

Fuchs Endothelial Dystrophy Trial in Portland (Glanatec, Optive, Ophthalmic Solution, Descemet Membrane Endothelial

Recruiting
  • Fuchs Endothelial Dystrophy
  • Portland, Oregon
    Devers Eye Institute
Sep 2, 2021

Corneal Edema, Corneal Endothelial Dysfunction Trial (AURN001)

Not yet recruiting
  • Corneal Edema
  • Corneal Endothelial Dysfunction
  • AURN001
  • (no location specified)
Sep 11, 2023

Fuchs' Endothelial Dystrophy, Cataract Trial in Boston (Netarsudil 0.02% Ophthalmic Solution)

Completed
  • Fuchs' Endothelial Dystrophy
  • Cataract
  • Netarsudil 0.02% Ophthalmic Solution
  • Boston, Massachusetts
    Massachusetts Eye and Ear Infirmary
Jan 24, 2021

Fuchs' Endothelial Dystrophy, Cataract Trial in Singapore (Ripasudil, Placebo)

Recruiting
  • Fuchs' Endothelial Dystrophy
  • Cataract
  • Singapore, Singapore
    Singapore National Eye Centre
Sep 15, 2023

Erectile Dysfunction, Diabetes Trial in Qina (Nitric oxide synthase gene)

Not yet recruiting
  • Erectile Dysfunction
  • Diabetes Mellitus
  • Nitric oxide synthase gene
  • Qinā, Egypt
    Qena Hospital
May 23, 2023

Fuchs' Endothelial Dystrophy Trial in Boston (Netarsudil Ophthalmic)

Recruiting
  • Fuchs' Endothelial Dystrophy
  • Netarsudil Ophthalmic
  • Boston, Massachusetts
    Massachusetts Eye and Ear Infirmary
Aug 23, 2022

Exfoliation Syndrome, Ocular Hypertension, Open Angle Glaucoma Trial in New York (AR-12286)

Completed
Has Results
  • Exfoliation Syndrome
  • +2 more
  • New York, New York
    Glaucoma Associates of New York
Oct 17, 2018

The Continuous Positive Airway Pressure Effect on Rho-associated

Recruiting
  • Obstructive Sleep Apnea
    • Keelung, Taiwan
      Sleep center
    Sep 18, 2021

    Retinitis Pigmentosa Trial (ZVS203e)

    Not yet recruiting
    • Retinitis Pigmentosa
    • (no location specified)
    Mar 27, 2023

    Chronic Graft-versus-host-disease Trial in United States (Belumosudil 200 mg QD, Belumosudil 200 mg BID, Belumosudil 400 mg QD)

    Active, not recruiting
    • Chronic Graft-versus-host-disease
    • Belumosudil 200 mg QD
    • +2 more
    • Duarte, California
    • +7 more
    Aug 5, 2022

    Pain, Acute Trial in New Taipei City (hydrogen inhalation, 4% concentration, given via nasal cannula)

    Recruiting
    • Pain, Acute
    • hydrogen inhalation, 4% concentration, given via nasal cannula
    • New Taipei City, Taiwan
      Fu Jen Catholic University Hospital
    Jul 25, 2022

    Dementia Trial in Australia, United States (Oral Fasudil 90 mg/day, Oral Fasudil 180 mg/day, Oral Placebo)

    Completed
    • Dementia
    • Oral Fasudil 90 mg/day
    • +2 more
    • Stamford, Connecticut
    • +10 more
    Jul 7, 2022

    Breast Cancer, Metastatic Breast Cancer, Cancer Therapy-Related Cardiac Dysfunction Trial in Lørenskog (Nicotinamide Riboside,

    Not yet recruiting
    • Breast Cancer
    • +4 more
    • Nicotinamide Riboside
    • Placebo
    • Lørenskog, Akershus, Norway
      Akershus University Hospital
    Feb 14, 2023

    Retinitis Pigmentosa Trial in Pittsburgh, Paris (SPVN06)

    Not yet recruiting
    • Retinitis Pigmentosa
    • Pittsburgh, Pennsylvania
    • +1 more
    Feb 17, 2023

    Hypertension in High School Students

    Completed
    • Hypertension in Adolescence
    • Adolescent Overweight
      • Milan, Italy
        IRCCS Ospedale San Raffaele
      Sep 17, 2023